Asimenia Angelidou to Vaccines
This is a "connection" page, showing publications Asimenia Angelidou has written about Vaccines.
Connection Strength
1.235
-
Angelidou A, Evans J, Idoko O, Levy O, Lewis NP, Nanishi E, Odumade OA, Ozonoff A, Plotkin S, Sherman AC, van Haren SD, Weitzman ER. Precision Vaccines: Lessons Learned From the Coronavirus Pandemic. Clin Infect Dis. 2022 08 15; 75(Suppl 1):S1.
Score: 0.670
-
Diray-Arce J, Chang AC, Moradipoor S, Amodio D, Carleton B, Chang WC, Crawford NW, Karoly M, Hoch A, McEnaney K, Kafil TS, Donthireddy M, Steltz SK, van Haren SD, Angelidou A, Smolen KK, Steen H, Lasky-Su J, Tran H, Liu P, Creech CB, Cutland CL, Petousis-Harris H, Nazy I, Yeung RSM, Kochhar S, Black S, Wood N, Nordenberg D, Palma P, Ovsyannikova IG, Kennedy RB, Poland GA, Ozonoff A, Chen RT, Levy O, Top KA. Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkers. Vaccine. 2025 Aug 30; 62:127504.
Score: 0.206
-
Weitzman ER, Pierce SE, Blakemore LM, Murdock A, Angelidou A, Dowling DJ, Levy O, Levy S. Need for strategic communications and stakeholder engagement to advance acceptability of an overdose preventing vaccine targeting fentanyl. Vaccine. 2024 10 24; 42(24):126082.
Score: 0.191
-
Nanishi E, Angelidou A, Rotman C, Dowling DJ, Levy O, Ozonoff A. Precision Vaccine Adjuvants for Older Adults: A Scoping Review. Clin Infect Dis. 2022 08 15; 75(Suppl 1):S72-S80.
Score: 0.168